FDA 植物药监管再审视：对中药质量监管与证据评价的思考与启示——基于2026 年RFI 与FDA/EMA 联合研讨会
钱忠直, 宋宗华
Re-examining FDA Botanical Drug Regulation: Reflections and Implications for TCM Quality Regulation and Evidence Evaluation —Based on the 2026 RFI and the Joint FDA/EMA Workshop
QIAN Zhong-zhi, SONG Zong-hua
中国食品药品监管
.
2026, (10): 18
-27
.
DOI: 10.3969/j.issn.1673-5390.2026.10.002
京公网安备11010802023381号